Related Experiment Videos
[Perinatal HIV transmission prophylaxis in the Liege region]
Y Jacquet1, C Hoyoux, M F Dresse
1Département de Pédiatrie, Hémato-oncologie, Université de Liège.
Revue Medicale De Liege
|November 12, 1998
Summary
The ACTG 076 protocol significantly reduced HIV vertical transmission from 25.6% to 8.7% by treating pregnant women and newborns with AZT. Early PCR detection is promising but requires time for definitive newborn infection status.
Area of Science:
- Virology
- Pediatrics
- Obstetrics
Context:
- Implementation of the ACTG 076 protocol in Liège since February 1994 for preventing perinatal HIV transmission.
- Antiretroviral therapy (ART) using AZT for pregnant women during gestation and delivery.
Purpose:
- To evaluate the effectiveness of the ACTG 076 protocol in reducing vertical HIV transmission.
- To assess the utility of Polymerase Chain Reaction (PCR) for early infant diagnosis.
- To investigate the role of intrapartum transmission and determine the safest delivery method.
Summary:
- The ACTG 076 protocol, involving AZT treatment for mothers and newborns, decreased HIV vertical transmission rates from 25.6% to 8.7%.
- Polymerase Chain Reaction (PCR) shows potential for early HIV detection in newborns, though definitive diagnosis isn't possible within the first week.
- Ongoing research aims to understand intrapartum transmission to establish optimal delivery practices.
Impact:
- Significant reduction in mother-to-child HIV transmission rates.
- Improved diagnostic capabilities for early detection of HIV in neonates.
- Informed strategies for safer delivery methods to minimize infant infection risk.